Episode 49 — October 2018
Christopher Loh of Fitzpatrick Cella Harper & Scinto in New York City discusses the Amgen v. Sanofi CAFC decision and his paper “End of ‘well characterized antigen’ test?” (Length: 20:08)
Christopher Loh of Fitzpatrick Cella Harper & Scinto in New York City discusses the Amgen v. Sanofi CAFC decision and his paper “End of ‘well characterized antigen’ test?” (Length: 20:08)